These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28096287)

  • 1. Prediction models for exacerbations in patients with COPD.
    Guerra B; Gaveikaite V; Bianchi C; Puhan MA
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28096287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.
    Bertens LC; Reitsma JB; Moons KG; van Mourik Y; Lammers JW; Broekhuizen BD; Hoes AW; Rutten FH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():493-9. PubMed ID: 24143086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources.
    Hoogendoorn M; Feenstra TL; Boland M; Briggs AH; Borg S; Jansson SA; Risebrough NA; Slejko JF; Rutten-van Mölken MP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3183-3194. PubMed ID: 29138546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
    Kaplan AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2535-48. PubMed ID: 26648711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
    Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.
    Vogelmeier CF; Chapman KR; Miravitlles M; Roche N; Vestbo J; Thach C; Banerji D; Fogel R; Patalano F; Olsson P; Kostikas K; Wedzicha JA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1125-1134. PubMed ID: 29692607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease.
    Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Sasabuchi Y; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1605-1611. PubMed ID: 28615933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.
    Calverley PM; Anzueto AR; Dusser D; Mueller A; Metzdorf N; Wise RA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1297-1308. PubMed ID: 29719385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and characterization of COPD exacerbations using real-time data collection.
    Ejiofor SI; Stolk J; Fernandez P; Stockley RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():427-434. PubMed ID: 28182151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
    Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of clinical control in COPD as a new tool for optimizing treatment.
    Soler-Cataluña JJ; Marzo M; Catalán P; Miralles C; Alcazar B; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3719-3731. PubMed ID: 30532528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.